Stock Groups

Novartis launches new share buyback of up to $15 billion -Breaking

by Mike Robinson

[ad_1]

© Reuters. FILE PHOTO – The logo of Novartis, a Swiss pharmaceutical company is visible at its plant in Stein (Switzerland), October 23, 2017. REUTERS/Arnd Wiegmann/File Photo

ZURICH, Reuters – Novartis AG stated on Thursday that they would be launching a share buyback worth up to $15 billion by the end 2023. The company also said it was optimistic about its top line growth prospects and extensive pipeline.

Swiss pharmaceutical company, Swiss Pharma Company confirmed that it expects sales growth of at least 4% through 2026. The company stated in a statement that its capital allocation strategy seeks to mix investing in core business with returning capital to shareholders.

Disclaimer: Fusion MediaThis website does not provide accurate and current data. CFDs include stocks, indexes and futures. Prices are provided not by the exchanges. Market makers provide them. Therefore, prices can be inaccurate and differ from actual market prices. These prices should not be used for trading. Fusion Media does not accept any liability for trade losses that you may incur due to the use of these data.

Fusion MediaFusion Media and anyone associated with it will not assume any responsibility for losses or damages arising from the use of this website’s data including quotes, charts, or buy/sell signal information. Trading the financial markets is one of most risky investment options. Please make sure you are fully aware about the costs and risks involved.

[ad_2]